GL1X · GenesisL1 explorer

Research workbench

Crystal structure of the regulatory domain of licms in complexed with isoleucine - type II

Analyse Crystal structure of the regulatory domain of licms in complexed with… in the GL1X research workbench: secondary structure, accessibility, pockets, interfaces, conservation, variants, modifications, peptides, crosslinks and neighbours on the 3D structure.

PDB
3F6G
Type
protein
Length
236 residues
Chains
2
Method
x-ray diffraction
Collection
MolNFT v1 / PDB
Contract
0xDE3723766Bc32dcACD03C17BaA400A7B36837Eba
Owner
0x3396CDB397284571d12822B4ae1189a8E22AAAAA
Molecule
Alpha-isopropylmalate synthase
EC
2.3.1.182
UniProt
Q8F3Q1
Ligands
ILE, ZN, SO4
Pockets
1 · best druggability 0.68

Structure

x-ray diffraction · 2 distinct chains · 29% helix, 43% strand (DSSP).

ChainMoleculeTypeResiduesSecondary structureUniProt
BAlpha-isopropylmalate synthase (EC 2.3.1.182)protein11528% helix, 43% strandQ8F3Q1
AAlpha-isopropylmalate synthase (EC 2.3.1.182)protein12130% helix, 43% strandQ8F3Q1

Ligands and binding sites

  • ILE · Isoleucine · ligand · 2 copies · chains B, A
  • ZN · Zinc ion · metal · 2 copies · chains B, A
  • SO4 · Sulfate ion · ion · 8 copies · chains B, A

Binding sites are the residues within 4.5 Å of a ligand's heavy atoms.

Pockets

1 pocket found on a 1 Å grid, 1 with a druggability of 0.5 or more.

PocketVolume (ų)DruggabilityBuriednessLining residuesInside
1500.680.9724ILE

Interfaces

1 interface between chains.

  • B–A · 1671 Ų buried · 29 hydrogen bonds · protein-protein

Compared structures

  • 3F6G · Crystal structure of the regulatory domain of LiCMS in complexed with isoleucine - type II · the same entry in another collection · chain A against A, TM-score 1.00
  • Q8F3Q1 · AlphaFold monomer V2.0 prediction for (R)-citramalate synthase cima (Q8F3Q1) · a predicted model of the same protein · chain B against A, TM-score 0.98

Analyse

GL1X is a live explorer of the GenesisL1 blockchain. Turn on JavaScript for search, charts and interactive views.